← Back to Search

Dietary Supplement

Health and Wellness Products for Cognitive Functioning

N/A
Waitlist Available
Led By Emily K. Pauli, PharmD
Research Sponsored by Radicle Science
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights

Study Summary

This trial tested how health products affect mental clarity and other health outcomes. Results were compared against a placebo.

Who is the study for?
Adults over 21 in the U.S. who want to improve their concentration can join this study. They must be willing to take an unknown product (active or placebo) and have internet access. Excluded are those with liver/kidney disease, heart issues incompatible with ingredients, current clinical trial participants, pregnant/breastfeeding individuals, heavy drinkers, and certain medication users.Check my eligibility
What is being tested?
The Radicle Clarity study is testing various health and wellness products against placebos to see if they improve mental clarity. Participants won't know if they're getting a real product or a placebo until the end of the randomized and blinded trial.See study design
What are the potential side effects?
Since specific side effects aren't listed for these health products, general possible side effects may include digestive discomfort, allergic reactions, headaches or dizziness; however individual experiences will vary.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in cognition (mental clarity)
Secondary outcome measures
Change in anxiety
Change in energy (fatigue)
Change in executive functioning
+4 more

Trial Design

13Treatment groups
Experimental Treatment
Placebo Group
Group I: Active Product 5.2Experimental Treatment1 Intervention
Clarity Product Form 5 - active product 2
Group II: Active Product 5.1Experimental Treatment1 Intervention
Clarity Product Form 5 - active product 1
Group III: Active Product 4.3Experimental Treatment1 Intervention
Clarity Product Form 4 - active product 3
Group IV: Active Product 4.2Experimental Treatment1 Intervention
Clarity Product Form 4 - active product 2
Group V: Active Product 4.1Experimental Treatment1 Intervention
Clarity Product Form 4 - active product 1
Group VI: Active Product 3.1Experimental Treatment1 Intervention
Clarity Product Form 3 - active product 1
Group VII: Active Product 2.1Experimental Treatment1 Intervention
Clarity Product Form 2 - active product 1
Group VIII: Active Product 1.1Experimental Treatment1 Intervention
Clarity Product Form 1 - active product 1
Group IX: Placebo Control 4Placebo Group1 Intervention
Clarity Product Form 4 - control
Group X: Placebo Control 3Placebo Group1 Intervention
Clarity Product Form 3 - control
Group XI: Placebo Control 5Placebo Group1 Intervention
Clarity Product Form 5 - control
Group XII: Placebo Control 2Placebo Group1 Intervention
Clarity Product Form 2 - control
Group XIII: Placebo Control 1Placebo Group1 Intervention
Clarity Product Form 1 - control

Find a Location

Who is running the clinical trial?

Radicle ScienceLead Sponsor
17 Previous Clinical Trials
31,767 Total Patients Enrolled
1 Trials studying Cognitive Functioning
501 Patients Enrolled for Cognitive Functioning
Emily K. Pauli, PharmDPrincipal InvestigatorRadicle Science, Inc
13 Previous Clinical Trials
24,240 Total Patients Enrolled
1 Trials studying Cognitive Functioning
501 Patients Enrolled for Cognitive Functioning

Media Library

Clarity Active Study Product 1.1 Usage (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT05652725 — N/A
Cognitive Functioning Research Study Groups: Placebo Control 4, Placebo Control 3, Active Product 4.2, Active Product 4.1, Placebo Control 5, Active Product 5.1, Placebo Control 2, Active Product 5.2, Placebo Control 1, Active Product 1.1, Active Product 3.1, Active Product 4.3, Active Product 2.1
Cognitive Functioning Clinical Trial 2023: Clarity Active Study Product 1.1 Usage Highlights & Side Effects. Trial Name: NCT05652725 — N/A
Clarity Active Study Product 1.1 Usage (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05652725 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the criteria for participants in this experiment?

"This clinical trial is seeking 300 individuals with cognitive competence between 21 and 105 years of age. Those who meet these criteria have a chance to be accepted into this study."

Answered by AI

Does this clinical trial accept participants aged 80 and above?

"To be eligible for this trial, participants must have an age ranging between 21 and 105. Furthermore, there are separate trials designed to accommodate minors and people above the retirement threshold of 65 years old with 1 study and 12 studies respectively."

Answered by AI

Are there any vacancies left to join this investigation?

"The information on clinicaltrials.gov reveals that currently, this medical trial is not taking part in patient recruitment. This project was first posted on September 1st 2023 and the last update occured December 7th 2022. Though there are no longer any spots available for this study, 21 other trials remain open to new participants at present."

Answered by AI
~2145 spots leftby Apr 2025